Journals / Ankara Medical Journal / 2022 / Cilt: 22 - Sayı: 2

WHAT ARE THE PARAMETERS THAT PREDICT THE DEVELOPMENT OF NEPHROLITHIASIS AND OSTEOPOROSIS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM?

Pages
249–259
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: While biochemical parameters are useful in predicting nephrolithiasis in patients with PHPT, the development of osteoporosis seems to be less related to biochemical parameters.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Primary hyperparathyroidism (PHPT) is associated with an increased risk of nephrolithiasis and osteoporosis, and predicting the development of these diseases will reduce PHP-related morbidities.
📊
Key Findings & Data:Materials and Methods: A total of 311 patients with PHPT due to parathyroid adenoma were evaluated retrospectively.
💡
Conclusion & Impact:Conclusion: While biochemical parameters are useful in predicting nephrolithiasis in patients with PHPT, the development of osteoporosis seems to be less related to biochemical parameters.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Primary hyperparathyroidism (PHPT) is associated with an increased risk of nephrolithiasis and osteoporosis, and predicting the development of these diseases will reduce PHP-related morbidities. Materials and Methods: A total of 311 patients with PHPT due to parathyroid adenoma were evaluated retrospectively. The patients were divided into groups, as patients with and without nephrolithiasis and those with and without osteoporosis. Demographic and biochemical variables that could predict the development of nephrolithiasis and osteoporosis in these groups were examined. Results: Nephrolithiasis was observed in 24.44% of 311 PHPT patients. Serum creatinine (Cr), serum calcium (Ca), adjusted Ca (adj Ca), albumin and 24-hour urinary phosphorus (24h uP) levels were higher, and serum P- value was significantly lower in patients with nephrolithiasis than those without nephrolithiasis. In the Receiver Operating Characteristic (ROC) analysis, serum Cr ≥0.66 mg/dl, adj Ca ≥10.72 mg/dl, serum P ≤2.71 mg/dl and 24h uP ≥635 mg/day cut-off values were found to have high sensitivity and low specificity values on the risk of developing nephrolithiasis. Of all patients, 43.09% had osteoporosis, and it was determined that only ≥50.50 years (sensitivity 81.34%, specificity 49.51%) and intact parathyroid hormone ≥ 201.50 pg/mL (sensitivity 75.14%, specificity 41.04%) values could predict osteoporosis (Area Under the ROC curve ranged from 0.57 to 0.67). Conclusion: While biochemical parameters are useful in predicting nephrolithiasis in patients with PHPT, the development of osteoporosis seems to be less related to biochemical parameters.

🔖

Cite This Article

TOPALOĞLU, O., ÇAKIR, B., ERDOĞAN, B. T., DEMİR, P., AYDIN, C., ERSOY, R., BAŞER, H., TAM, A. A. (2022). WHAT ARE THE PARAMETERS THAT PREDICT THE DEVELOPMENT OF NEPHROLITHIASIS AND OSTEOPOROSIS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM?. Ankara Medical Journal, Cilt: 22 - Sayı: 2, 249–259. https://ajindex.com/articles/441664

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Walker MD, SilverbergSJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018;14(2):115–25
  2. Silverberg SJ, Clarke BL, Peacock M, et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3580–94
  3. De Geronimo S, Romagnoli E, Diacinti D, D’Erasmo E, Minisola S. The risk of fractures in postmenopausal women with primary hyperparathyroidism. Eur J Endocrinol. 2006;155(3):415–20
  4. Khosla S, Melton LJ III, Wermers RA, Crowson CS, O’Fallon Wm, Riggs B. Primary hyperparathyroidismand the risk of fracture: a population-based study. J Bone Miner Res. 1999;14(10):1700–7
  5. Liu M, Williams J, Kuo J, Lee JA, Silverberg SJ, Walker MD. Risk factors for vertebral fracture in primary hyperparathyroidism. Endocrine 2019;66(3):682–90
  6. Suh JM, Cronan JJ, Monchik JM. Primary hyperparathyroidism: Is there an increased prevalence of renal stone disease? Am J Roentgenol. 2008;191(3):908–11
  7. Cipriani C, Biamonte F, Costa AG, et al. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J Clin Endocrinol Metab. 2015;100(4):1309–15
  8. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3561–9
  9. Berger AD, Wu W, Eisner BH, et al. Patients with primary hyperparathyroidism-why do some form stones? J Urol. 2009;181(5):2141–5
  10. Hosmer DW, Lemeshow S, Sturdivant RX. Applied Logistic Regression. 3rd ed. Wiley; 2013:177
  11. Rejnmark L, Vestergaard P, Mosekilde L. Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab. 2011;96(8):2377–85
  12. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999;341(17):1249–55
  13. Reid LJ, Muthukrishnan B, Patel D, Seckl JR, Gibb FW. Predictors of nephrolithiasis, osteoporosis, and mortality in primary hyperparathyroidism. J Clin Endocrinol Metab. 2019;104(9):3692-3700
  14. Patron P, Gardin JP, Paillard M. Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism. Kidney Int. 1987;31(5):1174–80
  15. Saponaro F, Cetani F, Mazoni L, et al. Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomat